Recruiting
Phase 1
Phase 2

Sirtuin-NAD Activator

Sponsor:

Brigham and Women's Hospital

Code:

NCT05040321

Conditions

Alzheimer's Disease (Incl Subtypes)

Dementia

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

MIB-626

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-19. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2025-03-10.